Compare PHAR & ECX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | PHAR | ECX |
|---|---|---|
| Founded | 1988 | 2017 |
| Country | Netherlands | United Kingdom |
| Employees | N/A | 1432 |
| Industry | Biotechnology: Pharmaceutical Preparations | EDP Services |
| Sector | Health Care | Technology |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.2B | 415.4M |
| IPO Year | 2020 | N/A |
| Metric | PHAR | ECX |
|---|---|---|
| Price | $12.61 | $0.98 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 3 | 0 |
| Target Price | ★ $38.33 | N/A |
| AVG Volume (30 Days) | 10.3K | ★ 1.1M |
| Earning Date | 05-07-2026 | 05-12-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | $10.04 | $819.14 |
| Revenue Next Year | $2.51 | $32.36 |
| P/E Ratio | $3,041.22 | ★ N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $9.54 | $0.88 |
| 52 Week High | $21.34 | $2.70 |
| Indicator | PHAR | ECX |
|---|---|---|
| Relative Strength Index (RSI) | 29.63 | 36.81 |
| Support Level | $11.43 | $0.88 |
| Resistance Level | $17.41 | $1.28 |
| Average True Range (ATR) | 0.49 | 0.08 |
| MACD | -0.25 | -0.01 |
| Stochastic Oscillator | 15.34 | 10.94 |
Pharming Group is a biotechnology company focused on developing and commercializing therapies for rare and ultra-rare diseases, particularly immunological and genetic conditions with high unmet need. It operates as an integrated company with capabilities across clinical development, manufacturing, regulatory affairs, and commercialization, supported by scientific and operational expertise. It leverages its efficient infrastructure to expand its pipeline and improve patient access to treatment. The Company operates in the United States, Europe, and the rest of the world, with the United States contributing the majority of its revenue.
ECARX Holdings Inc is engaged in the sales of system-on-chip core modules, automotive computing platform products, and software stacks as well as the provision of research and development services in the Peoples Republic of China. The companies core products include infotainment head units, digital cockpits, vehicle chip-set solutions, a core operating system, and an integrated software stack. Beyond this, ECARX is developing a full-stack automotive computing platform. It is engaged in automotive intelligence and networking.